NEW YORK (GenomeWeb News) – Sony DADC and Axela today announced they are partnering to develop and manufacture smart consumables for Axela's dotLab mX detection system.
The platform combines diffractive optics technology and label-free sensing for the real-time detection of binding events and "full characterization of biomarkers through sequential probing," the companies said, adding that the resulting dynamic range and panel flexibility "is unachievable with any other commercially available product."
The partnership is expected to accelerate Axela's expansion into applied testing and diagnostics from the research markets, Axela COO Paul Smith said in a statement.
Alex Izmailov, vice president of product development and manufacturing for the Toronto-based firm added, "Sony DADC's precision sensors in combination with the inherent self-referencing properties of diffractive optics will make our system highly attractive not only for biomarker screening and assay development but also as the method of choice for robust, routine analysis."
Terms of the deal were not disclosed.
Today's announcement follows Sony DADC's deal with Maven Biotechnologies last week, also to develop and manufacture smart consumables.